RecruitingNCT07604610

Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian Populations

Epicardial Fat Tissue Assessed by Echocardiography in Russian and Asian Populations: Association With Chronic Non-Communicable Diseases and Risk Factors


Sponsor

National Medical Research Center for Therapy and Preventive Medicine

Enrollment

500 participants

Start Date

May 4, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Visceral obesity is a well-established risk factor for the development of chronic non-communicable diseases (NCDs). Epicardial fat tissue (EFT) is located on the surface of the myocardium and may directly affect cardiac function and contribute to structural and functional remodeling. According to the literature, increased EFT thickness is associated with a wide range of NCDs, disease severity, and prognosis. The aim of this study is to investigate the associations between EFT thickness and clinical and anamnestic parameters, as well as to evaluate the prognostic value of this parameter in patients aged 50-70 years from the Russian Federation, Kazakhstan, Uzbekistan, and Kyrgyzstan.


Eligibility

Min Age: 50 YearsMax Age: 70 Years

Inclusion Criteria2

  • Patients aged 50-70 years undergoing transthoracic echocardiography in inpatient or outpatient settings;
  • Ability and willingness to provide informed consent.

Exclusion Criteria3

  • Refusal to sign informed consent;
  • Inability to perform transthoracic echocardiography or poor image quality;
  • Severe psychiatric disorders.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Medical Research Center for Therapy and Preventive Medicine

Moscow, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07604610


Related Trials